125 related articles for article (PubMed ID: 11085959)
21. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.
Grönlund H; Hallmans G; Jansson JH; Boman K; Wikström M; de Faire U; Frostegård J
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):382-6. PubMed ID: 19369878
[TBL] [Abstract][Full Text] [Related]
22. Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy.
Virella G; Carter RE; Saad A; Crosswell EG; Game BA; ; Lopes-Virella MF
Clin Immunol; 2008 Jun; 127(3):394-400. PubMed ID: 18533284
[TBL] [Abstract][Full Text] [Related]
23. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators.
Bili A; Moss AJ; Francis CW; Zareba W; Watelet LF; Sanz I
Circulation; 2000 Sep; 102(11):1258-63. PubMed ID: 10982540
[TBL] [Abstract][Full Text] [Related]
24. High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.
Sjögren P; Fredrikson GN; Samnegard A; Ericsson CG; Ohrvik J; Fisher RM; Nilsson J; Hamsten A
Eur Heart J; 2008 Sep; 29(18):2218-26. PubMed ID: 18664466
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study.
Ahmed E; Trifunovic J; Stegmayr B; Hallmans G; Lefvert AK
Stroke; 1999 Dec; 30(12):2541-6. PubMed ID: 10582975
[TBL] [Abstract][Full Text] [Related]
26. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction.
Ridker PM; Kundsin RB; Stampfer MJ; Poulin S; Hennekens CH
Circulation; 1999 Mar; 99(9):1161-4. PubMed ID: 10069783
[TBL] [Abstract][Full Text] [Related]
27. Elevated autoantibodies against oxidized palmitoyl arachidonoyl phosphocholine in patients with hypertension and myocardial infarction.
Wu R; Shen G; Morris R; Patnaik M; Peter JB
J Autoimmun; 2005 Jun; 24(4):353-60. PubMed ID: 15913955
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic significance of typical immune reactions in myocardial infarction].
Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
[TBL] [Abstract][Full Text] [Related]
29. [Nonspecific immunity factors and elimination of circulating immune complexes in patients with myocardial infarct in the 1st phase of rehabilitation].
Chan G; Osipov SG; Sipatova MA; Soboleva VA; Nikitin AE
Kardiologiia; 1985 Aug; 25(8):35-7. PubMed ID: 4068457
[TBL] [Abstract][Full Text] [Related]
30. Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease.
Erkkilä AT; Närvänen O; Lehto S; Uusitupa MI; Ylä-Herttuala S
Atherosclerosis; 2005 Nov; 183(1):157-62. PubMed ID: 16216595
[TBL] [Abstract][Full Text] [Related]
31. Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M.
Kovanen PT; Mänttäri M; Palosuo T; Manninen V; Aho K
Arch Intern Med; 1998 Jul; 158(13):1434-9. PubMed ID: 9665352
[TBL] [Abstract][Full Text] [Related]
32. Exploring the Link between Hydrodynamic Size and Immunoglobulins of Circulating Immune Complexes in Rheumatoid Arthritis Patients.
Djukić T; Drvenica I; Kovačić M; Milanović S; Majerič D; Šefik-Bukilica M; Miletić M; Bugarski B; Ilić V
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542112
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
34. [Cardiolipin antibodies in patients with myocardial infarction and unstable angina pectoris].
Nasonov EL; Noeva EA; Kovalev VIu; Dragnev AG; Lopaeva OV; Ruda MIa
Kardiologiia; 1992 May; 32(5):32-4. PubMed ID: 1405256
[TBL] [Abstract][Full Text] [Related]
35. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.
Stampfer MJ; Krauss RM; Ma J; Blanche PJ; Holl LG; Sacks FM; Hennekens CH
JAMA; 1996 Sep; 276(11):882-8. PubMed ID: 8782637
[TBL] [Abstract][Full Text] [Related]
36. [Immunological characteristics of patients with acute coronary syndrome (unstable angina and myocardial infarction)].
Logacheva IV; Leshchinskiĭ LA; Zvorygin IA
Klin Med (Mosk); 1999; 77(4):23-5. PubMed ID: 10356912
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies against oxidatively modified lipoproteins and progression of carotid restenosis after carotid endarterectomy.
Meraviglia MV; Maggi E; Bellomo G; Cursi M; Fanelli G; Minicucci F
Stroke; 2002 Apr; 33(4):1139-41. PubMed ID: 11935073
[TBL] [Abstract][Full Text] [Related]
38. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
[TBL] [Abstract][Full Text] [Related]
39. Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.
Fredrikson GN; Hedblad B; Berglund G; Alm R; Ares M; Cercek B; Chyu KY; Shah PK; Nilsson J
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):872-8. PubMed ID: 12649091
[TBL] [Abstract][Full Text] [Related]
40. The immunogenicity of modified lipoproteins.
Lopes-Virella MF; Thorpe SR; Derrick MB; Chassereau C; Virella G
Ann N Y Acad Sci; 2005 Jun; 1043():367-78. PubMed ID: 16037258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
